-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Selling and Marketing Expense history and growth rate from 2014 to 2023.
- Heron Therapeutics, Inc. /De/ Selling and Marketing Expense for the quarter ending June 30, 2024 was $13.6M, a 35.8% decline year-over-year.
- Heron Therapeutics, Inc. /De/ Selling and Marketing Expense for the twelve months ending June 30, 2024 was $50.3M, a 35.9% decline year-over-year.
- Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2023 was $67.6M, a 18% decline from 2022.
- Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2022 was $82.5M, a 5.35% decline from 2021.
- Heron Therapeutics, Inc. /De/ annual Selling and Marketing Expense for 2021 was $87.2M, a 36.5% increase from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)